Check out your Company Bowl for anonymous work chats.
Register for our virtual hiring event on Dec 1, 4 p.m./ EST and speak with our HR and Hardware Engineering staff about working at Draper! We have remote and in-office positions available.
Three of Draper’s patents were showcased last night at the Boston Patent Law Association ’s Invented Here! ceremony. This event celebrates New England innovators, their inventions and the stories behind their innovations. Click the below link to learn more about the patents!
Draper has been selected by the United States Air Force as one of the contractors on a digital engineering contract that aims to increase the service’s ability to work on digital designs of its future platforms.
Big news! Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the company’s tissue-chip platform for advanced studies of viral infection.
Draper is honored to support two nationally recognized programs for promising students in the aerospace industry: the Patti Grace Smith Fellowship and the Brooke Owens Fellowship programs.
Last week Draper was honored to host Senator Markey, Senator Warren and the Deputy Secretary of Defense, Dr. Kathleen Hicks. The briefings for our distinguished visitors, showcased work Draper is doing in trusted and assured microelectronics and in biosecurity, as well as our work for US Army DEVCOM. (Pictured left to right) DCG US Army DEVCOM, David C. Trybula; Douglas A. Tamilio, director, CCDC Soldier Center; Senator Edward Markey; Deputy Secretary of Defense Dr. Kathleen Hicks; Senator Elizabeth Warren; David R. Shedd, chairman, Draper Board of Directors; Dr. William A. LaPlante, President & CEO, Draper.
Draper is developing modeling and simulation (M&S) software that will enable scientists and engineers in the military to understand the effectiveness of resilient positioning, navigation and timing (PNT) technology on combat missions.
In a first for science, a team of Draper-led researchers used wildtype SARS-CoV-2 to infect and replicate the disease on human tissue in an organ-on-a-chip device.
Every year, thousands of children are born with congenital heart valve defects, yet there are no prosthetic heart valves designed specifically for babies. Draper is working towards developing the LEAP™ Valve that is designed to grow with the child and would reduce the number of surgeries needed for 0-to-6-year-old children born with defects.
Major infectious diseases, like COVID-19, often go undetected until they spread. Rachel Fezzie, a biochemist and molecular biologist at Draper, and her colleagues are part of a team selected by the Defense Advanced Research Projects Agency - DARPA to develop a portable device for screening thousands of pathogens in minutes, not hours.
